Literature DB >> 8019753

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

G J Molderings1, E Colling, J Likungu, J Jakschik, M Göthert.   

Abstract

1. Spirally cut strips of the human saphenous vein and pulmonary artery were used to determine the pharmacological properties of the presynaptic prostanoid receptors involved in the modulation of sympathetic [3H]-noradrenaline release. Strips preincubated with [3H]-noradenaline were superfused with physiological salt solution containing inhibitors of uptake1 and uptake2 and rauwolscine to eliminate involvement of presynaptic alpha 2-adrenoceptors. Tritium overflow was evoked by transmural electrical stimulation (standard frequency: 2 Hz). 2. In the saphenous vein, prostaglandin E2 (PGE2) inhibited the electrically-evoked tritium overflow; at the highest concentration investigated, tritium overflow was inhibited by more than 75% and the pEC50 value was 7.00. These effects were mimicked by prostaglandin E1, the EP1/EP3 receptor agonist, sulprostone and the EP2/EP3 receptor agonist, misoprostol with the rank order (pEC50): sulprostone (8.60) > PGE1 (7.25) > misoprostol (6.96). This rank order of potency suggests that the inhibitory effect of the drugs is mediated by presynaptic EP3-receptors. In contrast, PGF2 alpha did not inhibit evoked tritium overflow; the IP/EP1 receptor agonist iloprost and the stable thromboxane A2 analogue U 46619 (9, 11-dideoxy-11 alpha,9 alpha-epoxy-methanoprostaglandin F2 alpha) produced inhibition only at concentrations above 1 microM. 3. The EP1-receptor antagonist, AH 6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) had no effect on the evoked tritium overflow nor did it modify the inhibitory effect of PGE2, further excluding involvement of inhibitory presynaptic EP1-receptors. 4. PGD2 caused a facilitation of evoked tritium overflow in the saphenous vein; this facilitation is probably mediated by presynaptic DP-receptors, since it was abolished by the selective DP-receptor antagonist, BW A868C (3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin).5. In the pulmonary artery, sulprostone (pECm value 8.35), misoprostol (7.70) and PGE2 (6.80)inhibited electrically-evoked tritium overflow. This rank order of potency is consistent with the involvement of inhibitory presynaptic EP3-receptors.6. These results suggest that the sympathetic nerve fibres of both human saphenous vein and pulmonary artery are endowed with presynaptic inhibitory EP3 receptors. The EP3-receptors do not interact with the alpha 2-autoreceptors. In addition, the human saphenous vein seems to be endowed with presynaptic facilitatory DP-receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019753      PMCID: PMC1910075          DOI: 10.1111/j.1476-5381.1994.tb14799.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

Review 1.  Local regulation of adrenergic neurotransmission.

Authors:  T C Westfall
Journal:  Physiol Rev       Date:  1977-10       Impact factor: 37.312

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

3.  Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release.

Authors:  C Allgaier; T Jäger; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

5.  Modulation of noradrenaline release in human saphenous vein via presynaptic alpha 2-adrenoceptors.

Authors:  M Göthert; E Schlicker; F Hentrich; N Rohm; H R Zerkowski
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

6.  Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries.

Authors:  M Nakajima; N Toda
Journal:  Prostaglandins       Date:  1984-03

7.  The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Authors:  H Giles; P Leff; M L Bolofo; M G Kelly; A D Robertson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

8.  Identification of presynaptic beta 2-adrenoceptors on the sympathetic nerve fibres of the human pulmonary artery.

Authors:  M Göthert; F Hentrich
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

9.  Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Presynaptic regulation of the release of catecholamines.

Authors:  S Z Langer
Journal:  Pharmacol Rev       Date:  1980-12       Impact factor: 25.468

View more
  8 in total

1.  Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.

Authors:  G J Molderings; D Frölich; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.

Authors:  S Werthwein; U Bauer; M Nakazi; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.

Authors:  R L Jones; D F Woodward
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

4.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

5.  Cultured chick sympathetic neurons: prostanoid EP1 receptor-mediated facilitation of noradrenaline release.

Authors:  C Allgaier; W Meder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

6.  E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.

Authors:  Deborah L Clarke; Mark A Giembycz; Hema J Patel; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

Review 7.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

8.  Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and Survival.

Authors:  Santiago Olaechea; Anne Gilmore; Christian Alvarez; Bhavani S Gannavarapu; Rodney Infante; Puneeth Iyengar
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.